We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Lycia Therapeutics

Aetna Wun Trombley

Lycia Therapeutics is the operator of a biotechnology firm that aims to research and produce first-in-class therapies. The company's lysosomal targeting chimeras (LYTACs) platform is used to develop therapeutics that degrade extracellular and membrane-bound proteins that drive a variety of difficult-to-treat diseases, such as cancer and autoimmune conditions, allowing doctors to obtain drugs to cure patients.

Biotechnology Companies

Medical Organizations

Pharmaceutical Companies

Health Care Companies

Carolyn Bertozzi

Versant Ventures

Redmile Group

Cowen Healthcare Investments

Alexandria Venture Investments

Real estate and healthcare venture capital firm

Invus

Strategic investor supporting owner-managers

Eli Lilly

RTW Investments

Venrock Healthcare Capital Partners

Supportful investor in the healthcare sector

Henderson Global Investors

Franklin Resources

American Asset Management Holding Company

Marshall Wace

Blue Owl

South San Francisco

City in San Mateo County, California, United States

United States of America

Country primarily located in North America

San Francisco Bay Area

Metropolitan area in California, United States

California

San Mateo County

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Manufacturing

Chemical Manufacturing

Pharmaceutical and Medicine Manufacturing

Nursing and Residential Care Facilities

Pharmaceutical Preparation Manufacturing

Health Care and Social Assistance

Health Care and Social Assistance, Health

Stanford University

Private research university in Stanford, California, USA

Nona Biosciences

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Chemicals And Allied Products

Health Services

Drugs

Offices And Clinics Of Other Health Practitioners

Pharmaceutical Preparations

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Leading extracellular protein degradation company

Protein engineering

Monoclonal antibody

jQuery

MySQL

WordPress

gsap

Yoast SEO

modernizr

OWL Carousel

cdnjs

Twitter Emoji (Twemoji)

jQuery Migrate

core-js

Unpkg

Flywheel

Lycia Therapeutics Funding & Investors

Total Amount Raised: $226,600,000

Lycia Therapeutics Funding Rounds

Series C Investors

Series B Investors

Series A Investors

💸 Investors

💻 Job Types

📚 Popular Blog Posts